Metformin inhibits the prometastatic effect of sorafenib in hepatocellular carcinoma by upregulating the expression of TIP30 | |
Guo, Zhigui; Cao, Manqing; You, Abin; Gao, Junrong; Zhou, Hongyuan; Li, Huikai; Cui, Yunlong; Fang, Feng; Zhang, Wei; Song, Tianqiang | |
刊名 | CANCER SCIENCE |
2016 | |
卷号 | 107期号:4 |
关键词 | Hepatocellular carcinoma human TIP30 protein metformin sorafenib thioredoxins |
ISSN号 | 1349-7006 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3625555 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Guo, Zhigui,Cao, Manqing,You, Abin,et al. Metformin inhibits the prometastatic effect of sorafenib in hepatocellular carcinoma by upregulating the expression of TIP30[J]. CANCER SCIENCE,2016,107(4). |
APA | Guo, Zhigui.,Cao, Manqing.,You, Abin.,Gao, Junrong.,Zhou, Hongyuan.,...&Zhang, Ti.(2016).Metformin inhibits the prometastatic effect of sorafenib in hepatocellular carcinoma by upregulating the expression of TIP30.CANCER SCIENCE,107(4). |
MLA | Guo, Zhigui,et al."Metformin inhibits the prometastatic effect of sorafenib in hepatocellular carcinoma by upregulating the expression of TIP30".CANCER SCIENCE 107.4(2016). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论